Kestra Advisory Services, LLC Exelixis, Inc. Transaction History

Kestra Advisory Services, LLC

$17.3 Billion
Q3 2024

A detailed history of Kestra Advisory Services, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 11,867 shares of EXEL stock, worth $422,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,867

Previous 17,160 30.84%

Holding current value

$422,583

Previous $385,000 20.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.96 - $27.6 $116,234 - $146,086	-5,293 Reduced 30.84%	11,867 $307,000
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $15,987 - $18,651	786 Added 4.8%	17,160 $385,000
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $18,778 - $22,278	-931 Reduced 5.38%	16,374 $388,000
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $38,885 - $48,742	2,020 Added 13.22%	17,305 $415,000
Q3 2023 Nov 09, 2023	SELL	$19.04 - $22.74 $192,151 - $229,492	-10,092 Reduced 39.77%	15,285 $333,000
Q2 2023 Aug 11, 2023	BUY	$18.17 - $20.48 $66,338 - $74,772	3,651 Added 16.8%	25,377 $484,000
Q1 2023 May 12, 2023	SELL	$16.3 - $19.41 $42,706 - $50,854	-2,620 Reduced 10.76%	21,726 $421,000
Q4 2022 Jan 31, 2023	SELL	$14.96 - $17.39 $5,789 - $6,729	-387 Reduced 1.56%	24,346 $390,000
Q3 2022 Nov 01, 2022	BUY	$15.68 - $22.27 $3,057 - $4,342	195 Added 0.79%	24,733 $388 Million
Q2 2022 Aug 12, 2022	BUY	$17.44 - $23.16 $33,013 - $43,841	1,893 Added 8.36%	24,538 $511,000
Q1 2022 Apr 26, 2022	BUY	$17.03 - $22.67 $46,849 - $62,365	2,751 Added 13.83%	22,645 $513,000
Q4 2021 Jan 20, 2022	BUY	$15.84 - $21.88 $95,610 - $132,067	6,036 Added 43.56%	19,894 $363,000
Q3 2021 Oct 19, 2021	SELL	$16.3 - $21.14 $16,626 - $21,562	-1,020 Reduced 6.86%	13,858 $292,000
Q2 2021 Jul 28, 2021	BUY	$17.95 - $25.56 $10,500 - $14,952	585 Added 4.09%	14,878 $271,000
Q1 2021 May 10, 2021	SELL	$20.53 - $25.22 $94,992 - $116,692	-4,627 Reduced 24.46%	14,293 $322,000
Q4 2020 Jan 20, 2021	BUY	$18.39 - $24.8 $84,520 - $113,980	4,596 Added 32.09%	18,920 $382 Million
Q3 2020 Nov 12, 2020	BUY	$20.67 - $26.94 $296,077 - $385,888	14,324 New	14,324 $350 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Exelixis, Inc. Transaction History